White Papers and Resources
Please find below the latest White Papers provided by agencies and companies within the healthcare and pharmaceutical industry. These are provided by external comoanies and are not approved of, checked or edited by PMLiVE or PMGroup Worldwide Ltd.
Addressing the Mental Health Strain in Communications
October 24, 2025 | White Papers and Resources |
As stress and burnout rise across UK communications, Fox&Cat’s Under the Tree sessions—now evolved into Minds on Matters—show how structured, skills-based support can reduce pressure …
Brought to you by Fox&Cat
Putting the Best Minds on the Hardest Matters
October 24, 2025 | White Papers and Resources |
Mental wellbeing is a defining challenge in health communications. High workloads, constant connectivity and leadership gaps are driving widespread burnout, with serious impacts on creativity, …
Brought to you by Fox&Cat
5 mistakes to avoid when creating clinical content marketing
October 23, 2025 | White Papers and Resources |
In this article, we’ll share 5 common mistakes that we’ve uncovered in our years of experience creating clinical content. Helping you avoid these mistakes is …
Brought to you by Springer Nature
Are digital communications losing the human touch?
October 14, 2025 | White Papers and Resources |
Are you looking to ensure digital communications for healthcare professionals and patients still include the human touch? Here’s how.
Brought to you by Say Communications
Stories of sickness: applying illness narratives to health advertising
October 7, 2025 | White Papers and Resources |
By Dr Stephanie Goley Introduction As advertisers, we know that health and pharmaceutical campaigns hold enormous influence over how the public perceives illness, wellness, and …
Brought to you by 11 London
Regaining trust in childhood vaccines: can better comms turn the tables on hesitancy and misinformation?
October 6, 2025 | White Papers and Resources |
In the wake of Trump questioning MMR vaccines, we review the best practices in vaccine communications and consider how to reverse damage done to public …
Brought to you by Say Communications
Streamlining European expansion for cell and gene therapies
September 16, 2025 | White Papers and Resources |
Tom Smith, Strategic Director, Cell and Gene Therapies, Uniphar, discusses the essential elements biotechs need for commercial success in Europe’s unique market when developing cell …
Brought to you by Uniphar
Current CGT landscape and future outlook
September 16, 2025 | White Papers and Resources |
What makes CGT unique Cell and gene therapy (CGT) is a unique treatment that uses cells and genetic material to treat and cure diseases. Personalized …
Brought to you by Uniphar
Building for Success: Aligning Preclinical and Phase 1 Strategy with Commercial Goals
September 16, 2025 | White Papers and Resources |
This article concludes our three-part series on preparing cell and gene therapies (CGTs) for successful launch and long-term viability. The first article explored the unique …
Brought to you by Uniphar
Navigating the complexities of launch preparation for Cell and Gene Therapy
September 16, 2025 | White Papers and Resources |
Cell and gene therapies (CGT) provide transformative treatment that can treat conditions that were previously considered untreatable. As described in the previous article in this …
Brought to you by Uniphar